Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

Quantitative Measures of Time to Loss of 15% Vital Capacity and Survival Extension in Slowly Progressive Amyotrophic Lateral Sclerosis (ALS) Patients Treated with the Immune Regulator NP001 Suggests an Immunopathogenic Subset of ALS

  • Namita A. Goyal
  • , Jinsy A. Andrews
  • , Björn E. Oskarsson
  • , Martina H. Wiedau
  • , Edward J. Kasarskis
  • , Bruce D. Forrest
  • , Rongzhen Zhang
  • , Paige M. Bracci
  • , Matthew W. Davis
  • , Ari Azhir
  • , Michael S. McGrath

Producción científica: Article › revisión exhaustiva

Huella

Profundice en los temas de investigación de 'Quantitative Measures of Time to Loss of 15% Vital Capacity and Survival Extension in Slowly Progressive Amyotrophic Lateral Sclerosis (ALS) Patients Treated with the Immune Regulator NP001 Suggests an Immunopathogenic Subset of ALS'. En conjunto forman una huella única.
Clasificar por

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience

Biochemistry, Genetics and Molecular Biology

Immunology and Microbiology